SCHEMBL24318103

SCHEMBL24318103

CCc1csc([C@H](Cc2ccc(NS(=O)(=O)O)cc2)NC(=O)Cc2cccc(C)c2)n1

nearest known ligand 0.84

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTPRB P23467 20/20 0.84

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL500826 0.91 PTPRB (1.00) PTPRB
SCHEMBL30858801 0.91 PTPRB (1.00) PTPRB
SCHEMBL500123 0.91 PTPRB (1.00) PTPRB
SCHEMBL500827 0.91 PTPRB (1.00) PTPRB
SCHEMBL500124 0.91 PTPRB (1.00) PTPRB
SCHEMBL499660 0.91 PTPRB (1.00) PTPRB
SCHEMBL30055842 0.91 PTPRB (1.00) PTPRB
SCHEMBL499661 0.91 PTPRB (1.00) PTPRB
SCHEMBL500469 0.90 PTPRB (1.00) PTPRB
SCHEMBL500468 0.90 PTPRB (1.00) PTPRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3977994-A1 ACTIVATORS OF TIE-2 FOR USE IN TREATING INTRAOCULAR PRESSURE Aerpio Pharmaceuticals, Inc. (US) 2022-04-06 EP disclosed